Healthy Volunteers

A first-in-human, randomized, subject blinded, placebo controlled, single and multiple ascending intravenous dose study to assess the safety, tolerability and pharmacokinetics of LYS228 in healthy subjects

Participants must meet the following criteria

  • Male or female volunteers 18-60 years of age

Study Visits

  • 1 in-house stay of 6 nights/7 days.
  • 1 follow up visit
  • 1 phone call

Compensation

  • Up to $1,900 for time and travel